Atossa Therapeutics's total assets for Q2 2024 were $85.86M, a decrease of -5.74% from the previous quarter. ATOS total liabilities were $5.70M for the fiscal quarter, a 6.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.